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Introduction
Neonatal diabetes mellitus (NDM), defined as hypergly-
cemia that presents within the first month of life and that
requires insulin therapy, is a rare disorder, with an esti-
mated incidence of 1 in 400,000 live births
1-3). Clinically,
NDM is classified into two main categories, transient neo-
natal diabetes mellitus (TNDM) and permanent neonatal
diabetes mellitus (PNDM), which differ primarily in their
duration of insulin dependence. In TNDM, insulin secretion
is spontaneously recovered at a median age of 4 months
3).
However, PNDM requires lifelong insulin treatment
4).
Three genetic mechanisms have been shown to cause
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TNDM, including paternal uniparental disomy (UPD) of
chromosome 6
5), paternally inherited duplication of chromo-
some 6q24
6), and a methylation defect at a CpG island
(CGI) overlapping exon 1 of the ZAC or HYMAI gene
7).
These defects result in overexpression of a paternally
expressed allele at chromosome 6q24, which alters pan-
creatic -cell maturation and insulin secretion β
7, 8).
So far, only a few cases of TNDM have been reported
in Korea
9-12). We experienced a case of TNDM who pre-
sented with hyperglycemia, macroglossia, and intrauterine
growth retardation, apparently caused by a paternally-
derived HYMAI.
Case report
An 18-day-old girl was referred from the primary clinic
due to facial dysmorphism, poor weight gain, and recurrent
hyperglycemia detected at 16 days of life. She was born
at 40 weeks of gestation by spontaneous vaginal delivery
with a birth weight of 2,200 g (below 3rd percentile). No
one in the family was reported to have diabetes mellitus
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Transient neonatal diabetes mellitus (TNDM) has been associated with paternal uniparental isodisomy of chromosome 6,
paternally inherited duplication of 6q24, or a methylation defect at a CpG island of the ZAC or HYMAI gene. We expe-
rienced a case of TNDM in which the patient presented with hyperglycemia, macroglossia, and intrauterine growth retar-
dation, caused by a paternally derived HYMAI. An 18-day-old female infant was admitted to the hospital because of mac-
roglossia and recurrent hyperglycemia. In addition to the macroglossia, she also presented with large fontanelles, microg-
nathia, and prominent eyes. Serum glucose levels were 200 300 mg/dL and they improved spontaneously 2 days after –
admission. To identify the presence of a maternal methylated allele, bisulfite-treated genomic DNA from peripheral blood
was prepared and digested with BssHII after polymerase chain reaction (PCR) amplification with methylation-specific HYMAI
primers. PCR and restriction fragment length polymorphism analysis showed that the patient had only the paternal origin
of the HYMA1 gene. TNDM is associated with a methylation defect in chromosome 6, suggesting that an imprinted gene
on chromosome 6 is responsible for this phenotype. (Korean J Pediatr 2010;53:432-436)
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and the mother did not have gestational diabetes. The pa-
tient s length was 50 cm (50-75th percentile), her weight ’
2,690 g (10-25th percentile), and her head circumference
35.8 cm (75-90th percentile). She had extreme macro-
glossia, a prominent occiput, large fontanelles, micrognathia,
and prominent eyes. Overall, subcutaneous tissue was de-
creased. Laboratory findings showed a blood glucose level
of 280 mg/dL, serum C-peptide level of 0.79 ng/mL (nor-
mal range, 0.4-2.2 ng/mL), and 24hr urine C-peptide level
of 1.0 g/day (normal range, 2-260 g/day). Glycosuria μ μ
(3+) without ketonuria and acidosis was found and the
serum insulin level was below 0.1 IU/mL. Pancreatic μ
computed tomography was negative. Chromosome analysis
was performed and revealed a normal 46,XX female karyo-
type. Insulin therapy was initiated with regular insulin and
insulin doses of 0.1 unit/kg were injected intermittently
when blood glucose levels were above 200 mg/dL. Hyper-
glycemia improved spontaneously two days after admission
and insulin therapy was discontinued thereafter (Fig. 1).
She was discharged at 32 days of life. At 2 months of age,
she weighed 4.7 kg (10-25th percentile), and macroglossia
was in an improving state.
To test for methylation defect of chromosome 6, genomic
DNA was extracted from peripheral blood leukocytes and
was analyzed for methylation status of the HYMAI gene at
the conserved region of the differentially methylated region
(DMR) by methylation specific polymerase chain reaction
(MS-PCR) and restriction fragment length polymorphism
(RFLP). After PCR amplification of sodium bisulfite-treated
DNA, PCR products were digested with restriction enzymes
(BssHI) to distinguish between unmethylated (undigested)
bands and methylated (digested) bands. The enzymes were
chosen for their recognition sequences, which contain a CpG
dinucleotide. In this assay, a methylated cytosine will main-
tain the enzyme recognition site and consequently will be
cut, whereas an unmethylated cytosine will be converted
to uracyl, which will destroy the recognition site and there-
fore the site will remain undigested. MS-PCR analysis
identified the paternal origin of the HYMAI gene, which is
DMR; such that the paternal CGI were unmethylated and
the maternal CGI were methylated. No maternal part of
chromosome 6 was detected in the patient (Fig. 2).
Discussion
We have found a patient with TNDM with macroglossia,
who shows a lack of methylation of HYMAI gene in chro-
mosome 6. UPD of chromosome 6 suggests that two copies
of the paternal allele are necessary for the development of
TNDM; therefore, it is likely that an imprinted gene on
chromosome 6 is responsible for the diabetic phenotype
7).
Differential DNA methylation patterns between patients
with UPD of chromosome 6 and normal controls have been
demonstrated
7). TNDM associated with partial duplication
of the long arm of a paternal chromosome 6 also have also
been reported
8, 13). More recently, submicroscopic duplica-
tion and methylation mutations of the 6q24 region have
been found in patients with TNDM, implying that more sub-
tle changes of chromosome 6 may be involved
7). In 2000,
Gardner et al
7) showed that, in a number of TNDM cases,
the TNDM CGI was completely unmethylated on both
alleles, in the absence of UPD. They termed this a methy “ -
lation defect . Temple et al ”
14) performed genotype/pheno-
type study in TNDM patients confirmed by genetic analysis.
Fig. 1. Serial blood glucose changes in the patient.HY Jin, JH Choi, GH Kim, et al.
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However, no apparent phenotypic difference was observed
among the patients with UPD, duplication of 6q24, and a
methylation defect.
Two overlapping imprinted genes have been identified as
potential candidates for maternal allele silencing in the
chromosome 6q24 locus. The first is ZAC (zinc finger pro-
tein associated with apoptosis and cell cycle arrest), a zinc-
finger transcription factor involved in cell growth and apop-
tosis. Overexpression of ZAC might cause TNDM through
its function as a regulator of cell cycle arrest and apopto-
sis, altering the absolute number and efficiency of the - β
islet cells during a critical time of pancreatic development
in utero
15). The second gene in the region is HYMAI (im-
printed in hydatidiform mole), which encodes an untrans-
lated RNA whose function and role in TNDM is not known
16). The HYMAI gene exhibits allele-specific differential
DNA methylation pattern between the two parental alleles
at an adjacent CGI and is expressed only from the paternal
chromosome
17).
Molecular diagnosis of chromosome 6 anomalies provides
a tool to distinguish TNDM from PNDM in the neonatal
period. The ability to identify patients with a paternal UPD
of chromosome 6 allows the clinician to predict a transient,
rather than permanent, course of insulin treatment for dia-
betes mellitus and also to assure no increased recurrence
risk of TNDM in subsequent pregnancies. TNDM accounts
for 50-60% of cases of NDM
6) and the clinical course of
TNDM is characterized by intrauterine growth retardation,
failure to thrive, decreased adipose tissue, glycosuria, de-
hydration, and hyperglycemia requiring insulin for correc-
tion within the first few weeks of life
18, 19).
Differentiation between TNDM and PNDM is currently
based entirely on the persistent need for insulin in the per-
manent form. TNDM cannot be distinguished from PNDM
based on clinical features alone; therefore, these cannot aid
the clinician in determining the prognosis. It has been sug-
gested that there are several points that differentiate TNDM
and PNDM. For example, in TNDM, patients are younger
at the time of diagnosis of diabetes and have lower initial
insulin requirements
20). Macroglossia appears to be feature
more commonly associated with TNDM than with the PNDM
21). Patients with TNDM are also more likely to have in-
trauterine growth retardation and are less likely to develop
ketoacidosis and ketonuria than are patients with PNDM
20).
The high rate of intrauterine growth retardation is in kee-
ping with the crucial role of insulin in fetal growth and is
most likely caused by the failure of insulin secretion in fe-
tal life, especially during the last trimester of pregnancy
22).
TNDM is a developmental disorder of insulin production
that is usually resolved within 6 months. However, more
than 50% of patients with TNDM are prone to relapse to a
permanent diabetes state (type 2 diabetes) usually around
adolescence or as adults
3, 20, 23). TNDM, as a rare but dis-
tinct cause of neonatal diabetes, has a better prognosis
compared to many other causes of childhood diabetes. It is
the result of an imprinted gene at 6q24 and the genetic
cause can be identified in 80% of cases
14). A differentially
methylated CGI was found within the critical region and
was methylated only on the maternally inherited chromo-
some 6 homologs. All of the patients with paternal UPD of
chromosome 6 showed a complete lack of methylation at
this site
14). The region was also found to contain eight
Fig. 2. Methylation pattern of the HYMAI gene. Methylation-specific PCR analysis showed
that HYMAI is expressed only from the paternal allele. Therefore, the region appeared to
be differentially methylated, with a paternal unmethylated allele and a maternal methylated
allele. The patient (with the paternal methylation defect of chromosome 6) shows only an
unmethylated pattern, whereas the normal control exhibits a normal methylation pattern
(Lane M: DNA marker 100 bp ladder, Lane N: normal control, Lane Pt: patient). –TNDM with macroglossia diagnosed by MS-PCR
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CGIs. One CGI was shown to be differentially methylated
in normal subjects, such that the paternal CGI was unme-
thylated and the maternal CGI was methylated
7).
In the study reported here, we found a patient with
TNDM whose DNA methylation pattern was identical to
that reported for patients with a methylation defect of
chromosome 6. MS-PCR analysis is the first step for the
molecular diagnosis of TNDM. We can find out the presence
or absence of a maternal methylated allele through this
method. If no methylated allele is detected, microsatellite
analysis of chromosome 6 is required to identify UPD
24).
In Korea, Kwon et al
11) and Cho et al
12) reported TNDM
patients caused by UPD through microsatellite analysis.
Because methylation defect can be detected by MS-PCR,
we can distinguish TNDM from PNDM by using this method
before microsatellite analysis. This patient will require
long-term follow-up to determine whether recurrence of
diabetes mellitus in later life occurs in TNDM patients on
a consistent basis
25).
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일과성 신생아 당뇨병은 번 염색체의 부친 이체성 부친으로 6 ,
부터 유래한 염색체 의 중복 6q24 , ZAC 또는 HYMAI 유전자의
섬의 메틸화 결함에 의해 야기된다 저자들은 고혈당 거설 CpG . ,
증 자궁내성장지연으로 발현되어 부친으로부터 유래된 , HYMA1
유전자만을 보인 일과성 신생아 당뇨병 례를 경험하였다 생후 1 .
일된 여아가 거설증과 반복되는 고혈당으로 입원하였다 거설 18 .
증과 함께 큰 대천문 작은 턱 두드러진 눈을 보였으며 혈중 포 , ,
도당 농도는 로 유지되다가 입원 일 후부터 200-300 mg/dL 2
인슐린 투여 없이도 정상 범위로 유지되었다 모체로부터 유래된 .
메틸화된 대립유전자 유무를 확인하기 위하여 말초 혈액으로부터
를 추출하여 를 처리한 후 메틸화 특이 genomic DNA bisulfite ,
중합 효소 연쇄 반응으로 HYMAI 유전자의 일부분을 증폭시키고,
제한 효소 를 이용한 제한 효소 절편 길이 다형성 BssHII (res-
분석을 이용 triction fragment length polymorphism, RFLP)
하여 HYMAI 유전자의 메틸화 여부를 확인한 결과, HYMAI 유
전자의 메틸화 결함을 보여 부친에서 유래된 HYMAI 유전자만을
갖고 있음을 확인하였다. HYMAI 유전자의 메틸화 검사를 통해
번 염색체의 각인된 유전자가 증명되었으며 메틸화 결함으로 인 6
해 일과성 신생아 당뇨병이 발생하였다.
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